The National Institutes of Health operates under a peculiar immunity from public scrutiny. Its facilities handle some of the world’s deadliest pathogens while operating behind walls of bureaucratic silence, and when things go catastrophically wrong, the default response is not disclosure but damage control. The latest revelations about Rocky Mountain Laboratories in Hamilton, Montana, prove the point with damning clarity.
According to the White Coat Waste Project, the NIH quietly admitted in February that a deadly pathogen was “released, lost, or stolen” from the high-security facility. That unspecified declaration deserves scrutiny.
What pathogen? How long was it missing? Where was it when it went unaccounted for? These are not academic niceties. They are the questions that separate legitimate research oversight from institutional concealment.
A Pattern of Negligence Wrapped in Federal Authority
This is not an isolated incident at Rocky Mountain Laboratories. In January, White Coat Waste uncovered a separate breach in which an NIH staffer was bitten by a macaque that had been deliberately infected with Crimean-Congo Hemorrhagic Fever. The virus carries a 40 percent mortality rate in humans.
According to whistleblower testimony, the infected animal was kept in conditions described as torture, with no pain mitigation provided, and the entire incident was managed through what sources characterize as a coordinated coverup.
According to the allegations, NIH leadership moved into what insiders call “full coverup mode.” The exposed worker was quietly flown out, the broader laboratory campus was not informed of the biohazard exposure, and the incident remained hidden until external investigators brought it to light. This is not how responsible custodians of public health operate. This is institutional self-protection at the expense of democratic accountability.
More alarming still are allegations involving Vincent Munster, the chief of the virus ecology section at Rocky Mountain Laboratories and a protégé of Anthony Fauci. Whistleblowers claim Munster attempted to smuggle dozens of vials of viral hemorrhagic fever samples from Africa into the United States in January, misrepresenting the contents to customs officials.
He is now under active FBI criminal investigation, has been placed on administrative leave, and has been scrubbed from the official NIH employee directory.
Congressional Republicans Are Finally Asking the Right Questions
The revelations have triggered sharp responses from Republican leadership. Senator Tim Sheehy of Montana declared the allegations a potential “massive breach of trust with the people of Montana.” Senator Rick Scott called the incidents “really concerning.” Senator Joni Ernst, who has long sounded alarms about dangerous virus research at RML, demanded an end to funding for what she termed “batty research” before another pandemic is triggered.
Representative Paul Gosar noted he had warned the NIH in January about the facility’s risky bat research involving Ebola and its connections to EcoHealth Alliance, a nonprofit deeply involved in controversial gain-of-function research partnerships. The laboratory defended the work at the time, even as it was failing to contain basic biosafety protocols.
HHS Secretary Robert F. Kennedy Jr., who has been tasked with overhauling the nation’s health bureaucracies, weighed in with direct assessment. When informed of the allegations, he told White Coat Waste investigators, “I assume he is going to prison.” That clarity stands in sharp contrast to the routine equivocation and institutional protection that has historically characterized NIH responses to malfeasance.
The Deeper Problem Is Institutional, Not Personal
While individual misconduct deserves investigation and punishment, the structural problem runs far deeper. The NIH operates with minimal external accountability. Its facilities work with maximum-containment pathogens under cover of scientific necessity and national security. When accidents occur—and they do—the response is determined internally, often without meaningful public disclosure.
The White Coat Waste Project, a taxpayer watchdog organization, has been documenting waste and dangerous practices at NIH facilities for years. Its investigators rely on leaked documents, whistleblower tips, and Freedom of Information Act requests to surface information that should have been disclosed as a matter of routine public health governance. That private organizations must serve as de facto regulators of federal health agencies is itself an indictment of the system.
The facility’s location in rural Montana compounds the problem. Rocky Mountain Laboratories sits in a small town that was historically suspicious of the lab itself. When the facility was first conceived in 1928 to study Rocky Mountain spotted fever, residents feared pathogen escape so acutely that the laboratory added a ceremonial “tick moat” to allay public anxiety. A century later, with infinitely more dangerous pathogens under study, that same community receives less transparency, not more.
The federal health establishment has not operated on a just balance. It has obscured, minimized, and protected itself while asking the public to trust its judgment.
The Path Forward Requires Real Accountability
If these allegations prove accurate—and RFK Jr.’s confirmation to investigative journalists suggests they are serious enough to warrant that assessment—then reform must follow investigation. That means not only criminal accountability for individuals who violated protocols or obstructed oversight, but a fundamental restructuring of how NIH facilities operate and report incidents.
Congress should demand unredacted incident reports from Rocky Mountain Laboratories for the past five years. External biosafety auditors, not NIH personnel, should conduct regular assessments. A public health ombudsman with genuine independence should receive and investigate complaints from facility personnel without fear of retaliation. And gain-of-function research—the deliberate engineering of pathogenic properties in laboratory organisms—should be subject to transparent, rigorous public debate rather than insulated bureaucratic approval.
The stakes could not be higher. We live in a world where laboratory accidents with maximum-containment pathogens are not theoretical concerns but documented realities. The public has a right to know when and where they occur, not to read about them months or years later through leaked documents. That transparency is not anti-science. It is the prerequisite for public trust in institutions that exist to serve and protect the public health.
